logo
welcome
CNBC

CNBC

Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline

CNBC
Summary
Nutrition label

74% Informative

Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines.

The investment seeks to build upon Lilly 's success from Mounjaro and Zepbound , which are riding a wave of popularity in so-called GLP-1 drugs.

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer's disease, ALS and other brain diseases.

Ricks downplays the importance of hitting the trillion-dollar mark, saying it would be an outcome, not a goal, for Lilly . "We want to do valuable things, and if we're successful, we create value," Ricks said. "That's how we'll get to a bigger number.".

VR Score

80

Informative language

82

Neutral language

64

Article tone

semi-formal

Language

English

Language complexity

53

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links